Parameter | Value |
---|---|
Sex | |
Male | 70 (82.35) |
Female | 15 (17.65) |
Hepatitis B | |
Positive | 56 (65.88) |
Negative | 29 (34.12) |
Tumour number | |
Single | 65 (76.47) |
Multiple | 20 (23.53) |
Preoperative parameters | |
Age (year) | 44.71 ± 11.52 |
Platelet count (109/L) | 261.43 ± 85.68 |
Total bilirubin (μmol/l) | 15.51 ± 11.87 |
Albumin (g/L) | 39.05 ± 4.50 |
ALT (IU/L) | 45.53 ± 26.09 |
AST (IU/L) | 78.16 ± 62.08 |
Prothrombin time (s) | 12.86 ± 1.21 |
Alpha-foetoprotein (μg/ml) | 770.57 ± 1060.93 |
Body surface area (m2) | 1.95 ± 0.16 |
Tumour size (cm) | 11.37 ± 3.69 |
Remnant liver volume (ml) | 552.18 ± 214.32 |
SRLV (ml/m2) | 282.00 ± 96.20 |
Child–Pugh classification | |
A | 71 (83.53) |
B | 14 (16.47) |
Intraoperative parameters | |
Blood loss (ml) | 716.67 ± 650.96 |
Postoperative parameters | |
Tumour capsule | |
Yes | 75 (88.24) |
No | 10 (11.76) |
Macrovascular invasion | |
Yes | 64 (75.29) |
No | 21 (24.71) |
Hepatic fibrosis stage | |
No significant fibrosis | 31 (36.47) |
Severe fibrosis | 24 (28.24) |
Cirrhosis | 30 (35.29) |
Hospital stay (days) | 25.87 ± 6.56 |